Education
About Us
Working with TipRanks
Follow Us
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
RESEARCH TOOLSreports
SPLY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.13
Previous CloseN/A
Volume19.00K
Average Volume (3M)87.64K
Market Cap
C$10.14M
Enterprise ValueC$15.38M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.78
Next Earnings
Jan 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding169,025,220
10 Day Avg. Volume56,155
30 Day Avg. Volume87,636
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Origin Therapeutics Holdings, Inc. News
SPLY FAQ
What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?
Origin Therapeutics Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.13 in the past 12 months.
What is Origin Therapeutics Holdings, Inc.’s market cap?
Origin Therapeutics Holdings, Inc.’s market cap is C$10.14M.
When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?
Origin Therapeutics Holdings, Inc.’s upcoming earnings report date is Jan 26, 2026 which is in 139 days.
How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?
Origin Therapeutics Holdings, Inc. released its earnings results on Sep 02, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Origin Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Origin Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does Origin Therapeutics Holdings, Inc. pay dividends?
Origin Therapeutics Holdings, Inc. does not currently pay dividends.
What is Origin Therapeutics Holdings, Inc.’s EPS estimate?
Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Therapeutics Holdings, Inc. have?
Origin Therapeutics Holdings, Inc. has 169,025,220 shares outstanding.
What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Origin Therapeutics Holdings, Inc. reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:SPLY
Company Description
Origin Therapeutics Holdings, Inc.
Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.
Technical Analysis
Flow Capital Corp
―
Esstra Industries
―
ESG Global Impact Capital
―
Torrent Capital Ltd
―
The Western Investment Company of Canada Ltd
―
Options Prices
Currently, No data available
---